On October 31, 2023 HDT Bio Corp., a clinical-stage private company developing advanced RNA products to treat and prevent infectious diseases and cancer, reported that Dr. Steven Reed, Chief Executive Officer of HDT Bio, will present at the Society for Immunotherapy of Cancer (SITC) (Free SITC Whitepaper) 2023 Annual Meeting in San Diego, California, on November 3 (Press release, HDT Bio, OCT 31, 2023, View Source [SID1234636583]). Dr. Reed will deliver a presentation on the AMPLIFY vaccine platform as a novel technology for cancer immunoprevention.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
HDT’s AMPLIFY vaccine platform is based on its self-amplifying RNA (repRNA) combined with LION, its patented nanoparticle-based formulation technology. LION not only stabilizes, protects, and transports RNA during formulation and administration, but also enhances safety. This approach, compared to current RNA vaccines, allows for simplified manufacturing processes, improved temperature stability, and heightened safety, thereby enabling multivalency for more effective and efficient vaccine products.
"Cancer is a formidable adversary. Our presence at the SITC (Free SITC Whitepaper) 2023 Annual Meeting underscores our commitment to advancing the field of immunoprevention," said Dr. Steven Reed, CEO of HDT Bio. "With the AMPLIFY vaccine platform and products derived thereof, we are committed to transforming the landscape of cancer care, marking a monumental leap towards a future where cancer is no longer a looming threat but a preventable condition."
Details of the presentation are as follows:
Title: Novel Technologies for Cancer Immunoprevention
Presenter: Steven Reed, Ph.D.
Category: Immunoprevention of Cancer
Session: Concurrent Session 106c
Date: Friday, November 3 at 2:15 p.m. Pacific Time
Location: Ground Level, Exhibit Hall D, San Diego Convention Center